← Open Payments lookup

NPI 1912905464: Open Payments

NPI 1912905464. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,275 in 71 payments from 26 companies in 2025. Trend: 2023 $1,225 · 2024 $1,051 · 2025 $1,275

Food & beverage: $1,275
CompanyPaymentsAmount
Novo Nordisk Inc10$182
Abbott Laboratories8$137
Boehringer Ingelheim Pharmaceuticals, Inc.5$91
Lilly USA, LLC5$87
ABBVIE INC.5$79
GlaxoSmithKline, LLC.4$69
PFIZER INC.4$68
Phathom Pharmaceuticals, Inc.3$56
Dexcom, Inc.3$52
Boston Scientific Corporation2$48

Products named: FREESTYLE LIBRE 3, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Wegovy, JARDIANCE, VOQUEZNA, REXULTI.